Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence D True

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Urologic Oncology|September 3, 2025
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort studyDimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, et al.
American Journal of Cancer Research|September 15, 2021
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendationsRajal B Shah, Qi Cai, Manju Aron, et al.
Research Square|January 10, 2024
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATESAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Cancer Cell|October 11, 2017
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF SignalingEric G Bluemn, Ilsa M Coleman, Jared M Lucas, et al.
Molecular Cancer Research : MCR|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate CancerErolcan Sayar, Helen M Richards, Roman Gulati, et al.
NPJ Precision Oncology|May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
Histopathology|January 24, 2018
Utility of Pathology Imagebase for standardisation of prostate cancer gradingLars Egevad, Brett Delahunt, Daniel M Berney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant studyMary-Ellen Taplin, Bruce Montgomery, Christopher J Logothetis, et al.
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Urologic Oncology|September 3, 2025
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort studyDimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, et al.
American Journal of Cancer Research|September 15, 2021
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendationsRajal B Shah, Qi Cai, Manju Aron, et al.
Research Square|January 10, 2024
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATESAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Cancer Cell|October 11, 2017
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF SignalingEric G Bluemn, Ilsa M Coleman, Jared M Lucas, et al.
Molecular Cancer Research : MCR|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate CancerErolcan Sayar, Helen M Richards, Roman Gulati, et al.
NPJ Precision Oncology|May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
Histopathology|January 24, 2018
Utility of Pathology Imagebase for standardisation of prostate cancer gradingLars Egevad, Brett Delahunt, Daniel M Berney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant studyMary-Ellen Taplin, Bruce Montgomery, Christopher J Logothetis, et al.
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
Pageof 21